Historical AI Consensus
This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.
- Symbol
- AMPX.NYSE
- Batch
- 7
- Published
- September 20, 2026
- AI Advisors
- 14
Historical AI Consensus Investment Thesis
Amprius Technologies (AMPX) Stock Forecast and AI Rating
Forecast targets and rating
Published batch rating
NEUTRAL
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
NEUTRAL$11
+14.0%5-Year
NEUTRAL$18
+89.6%Published batch insight
Silicon Anode Energy Density Supremacy Clashes With Asset Light Contract Manufacturing Realities
Research reveals sharp divergence between accelerating defense unmanned aviation contract shipments and severe macroeconomic multiple compression. While outsourced manufacturing preserves liquidity and lifts gross profitability, ongoing working capital expansion, trans-Pacific trade exposure, and potential equity dilution cap per-share upside, requiring verifiable positive cash conversion to validate commercial execution.
This analysis preserves the original published batch. Audit published forecasts in full transparency
Sherlock Holmes (Whistleblower), Machiavelli (Insider), Elon Musk (Visionary), Universal Investor (Polymath), Superintelligence (Anthropologist), Michael Burry (Vulture), J.P. Morgan (Titan), Warren Buffett (Value Purist), Ray Dalio (Strategist). Some archetypes run in multiple modes, resulting in 14 advisors total.
Full published thesis
Executive Summary
If you invested $10,000 in Amprius Technologies at the forecast anchor (2026-09-18): $18,959 in five years versus $13,892 for S&P 500 benchmark.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter | Target (USD) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q4 2026 | 9.83 | +3.49% | +3.49% | Commercial shipments of 500 Wh/kg SiCore cells initiate revenue recognition across European defense programs. However, restrictive Federal Reserve discount rates and investor demand for audited cash conversion cap near-term multiple expansion, producing modest net consolidation. |
| Q1 2027 | 10.12 | +2.90% | +6.49% | Full-year 2026 financial reporting confirms revenue crossing 140 million dollars with initial positive adjusted EBITDA. Market sentiment absorbs higher domestic pre-production qualification expenses and seasonal defense order lulls, yielding balanced price discovery across institutional desks. |
| Q2 2027 | 10.47 | +3.49% | +10.21% | Expanded defense drone procurement under NATO budgets accelerates second-quarter shipments, narrowing GAAP operating losses. Domestic qualification progress with allied contract partners reinforces supply chain durability, partially offset by ongoing working capital requirements to finance inventory expansion. |
| Q3 2027 | 10.83 | +3.41% | +13.97% | Rising loitering munition replenishment orders provide solid revenue visibility, though working capital absorption and the expiration of legacy public warrants maintain focus on liquidity runway. Contract manufacturing yields stabilize, supporting steady operating performance. |
| Q4 2027 | 11.16 | +3.04% | +17.43% | Enactment of strict statutory bans on foreign cells across Western defense programs redirects procurement toward compliant silicon cells. Strong shipment volume drives gross margins toward twenty-eight percent, balancing transitional domestic tolling friction with robust sovereign backlogs. |
| Q1 2028 | 11.68 | +4.66% | +22.90% | Audited full-year 2027 results reveal revenue doubling toward 200 million dollars and approaching GAAP operating breakeven. Slower cash collection cycles and persistent long-term bond yields moderate valuation multiple expansion, prompting constructive quarterly price consolidation. |
| Q2 2028 | 12.27 | +5.09% | +29.16% | Commercial drone delivery platforms expand operational fleets, demonstrating revenue diversification beyond military programs. Contract toll lines in South Korea and domestic partners improve assembly yields, expanding gross margins and generating positive quarterly operational cash flow. |
| Q3 2028 | 12.58 | +2.54% | +32.44% | Defense prime integration deepens with multi-year tactical UAV framework renewals. Mild component price inflation and trade tariff scrutiny across trans-Pacific corridors temporarily temper sequential operating margin gains, though underlying backlog execution remains resilient. |
| Q4 2028 | 13.10 | +4.15% | +37.94% | High-altitude pseudo-satellite program deployments and initial commercial aviation pack shipments accelerate fourth-quarter deliveries. High-margin silicon cell mix expands corporate gross profitability, cementing technological leadership over conventional graphite chemistries and supporting steady equity appreciation. |
| Q1 2029 | 13.50 | +3.03% | +42.11% | Fiscal 2028 reporting demonstrates the first full year of positive GAAP operating income. Fundamental quality filters activate across institutional growth mandates, driving accumulation as the asset-light model proves self-funding without requiring dilutive equity financing. |
| Q2 2029 | 14.08 | +4.27% | +48.18% | Commercial eVTOL pre-production flight testing progresses on schedule, unlocking forward commercial aerospace pipeline opportunities. Broad industrial technology multiples experience mild beta drag from late-cycle monetary adjustments, but core military battery shipments maintain top-line growth. |
| Q3 2029 | 14.50 | +3.01% | +52.64% | NATO allied procurement formalizes standardized high-density silicon battery adoption for tactical reconnaissance airframes. Operating cash flow conversion improves as receivables collections normalize, validating scalable tolling economics and supporting constructive valuation multiple stability. |
| Q4 2029 | 15.01 | +3.53% | +58.03% | Municipal public-safety drone fleets and autonomous logistics networks initiate recurring pack replacement orders. Consistent production throughput across contracted lines sustains thirty percent gross margins, insulating the enterprise from broader cyclical economic slowdowns. |
| Q1 2030 | 15.54 | +3.48% | +63.53% | Full-year 2029 financial statements document annual revenue surpassing 350 million dollars with expanding net margins. The elimination of debt distress risks and consistent cash generation support steady equity accumulation among long-term institutional allocators. |
| Q2 2030 | 16.08 | +3.48% | +69.22% | Laboratory announcements of competing solid-state prototypes generate transient sector sentiment headwinds. Management clarifies that commercial aviation qualification moats remain intact, preserving customer retention and sustaining high-margin deliveries across established defense aviation contracts. |
| Q3 2030 | 16.23 | +0.95% | +70.83% | High-density battery pack integration expands into specialized terrestrial robotics and heavy agricultural inspection drones. Stable raw material procurement and diversified tolling lines protect unit profit margins against minor industrial input cost fluctuations. |
| Q4 2030 | 16.74 | +3.14% | +76.19% | Renewal of long-term sovereign defense contracts secures multi-year procurement visibility through the mid-2030s. Operational leverage converts incremental volume into expanding free cash flow, reinforcing the company's position as an indispensable specialty aerospace power supplier. |
| Q1 2031 | 17.26 | +3.14% | +81.73% | Fiscal 2030 audited earnings confirm annual revenue approaching 500 million dollars and robust net profits. Management discusses initial share buyback authorizations, signaling balance-sheet independence and supporting equity value as growth rates normalize toward mature industrial benchmarks. |
| Q2 2031 | 17.63 | +2.13% | +85.60% | Routine defense fleet refurbishment cycles provide highly predictable, high-margin recurring cash flows. Growth moderation in commercial mobility platforms induces minor valuation multiple compression, though operating profitability remains well protected by entrenched customer switching barriers. |
| Q3 2031 | 18.01 | +2.15% | +89.59% | Terminal horizon concludes with the enterprise established as a profitable, cash-generative defense and aerospace component supplier. Proven gravimetric performance moats and disciplined capital allocation anchor long-term valuation near normalized industrial hardware multiples. |
The investment thesis centers on whether asset-light silicon anode commercialization generates sufficient operational leverage to outrun severe multiple compression and working capital absorption. Exiting capital-intensive factory commitments for outsourced contract manufacturing expanded gross margins from negative territory to twenty-seven percent, capturing price-inelastic defense drone procurement across Western allies. However, trading near ten times forward sales in a restrictive discount-rate regime embeds elevated execution expectations. The critical economic tension lies between rapid top-line scaling and cash conversion, where uncollected receivables and ongoing partner qualification determine whether equity holders capture sustainable economic value or face further dilutive financing.
Key insights
- Contract tolling transfers capital expenditure burdens to external partners but exposes gross margins to supply tariffs, partner scheduling power, and quality variance.
- Expanding defense procurement creates non-cyclical revenue backlogs, yet rigorous military qualification standards and domestic content rules create substantial transitional margin friction.
- Rapid shipment growth without timely cash collections leaves working capital highly vulnerable, requiring verifiable cash conversion before the current multiple derating stabilizes.
The company is shifting from an experimental battery developer into a commercial supplier for high-performance military drones. By outsourcing cell production instead of building costly factories, profit margins turned positive while sales more than doubled. However, the stock already reflects strong growth expectations during high interest rates. Turning rapid deliveries into actual bankable cash without creating new shares remains the key hurdle for long-term investors.
Key insights
- Outsourced cell assembly saves expensive factory construction but leaves profit margins vulnerable to supplier fees and tariffs.
- Military drone demand provides strong ongoing orders, but meeting strict domestic defense standards causes temporary production friction.
- Sales are expanding quickly, but the business must collect cash faster to avoid diluting existing shareholders.
Deep Dive
The prevailing crowd consensus views the company as an emerging pure play on autonomous drone warfare and aviation electrification. Investors anchor on triple-digit top-line growth, sequential guidance increases, and positive gross margins, assuming outsourced manufacturing eliminates balance-sheet risk. However, market sentiment remains split between momentum buyers anticipating rapid commercial profitability and skeptics questioning revenue quality, high valuation multiples, and historical cash burn.